PlusCBD Oil Softgels

Description

1. Product Overview
The PlusCBD Oil Softgel is a standardized, full-spectrum hemp-derived cannabinoid preparation precision-encapsulated in a lipid-based softgel matrix for industrial formulation and white-label integration. Its primary industrial use is as a functional ingredient for nutraceutical, cosmeceutical, and OTC wellness products requiring consistent cannabinoid delivery. The key value proposition is batch-to-batch cannabinoid uniformity (>99% label claim accuracy) and enhanced bioavailability through proprietary carrier oil stabilization. Strategically, this product enables B2B buyers to de-risk regulatory exposure while accessing the high-margin CBD finished-goods market without upstream extraction or purification capital expenditure.

2. Key Specifications & Technical Characteristics

• Chemical composition: Full-spectrum hemp extract (containing CBD, minor cannabinoids: CBG, CBN, CBC; <0.3% delta-9 THC by dry weight), suspended in MCT coconut-derived carrier oil

• Purity level: 99.5%+ removal of chlorophyll, waxes, and heavy metals (ICP-MS verified); potency: 25 mg CBD per softgel ±3% variance

• Physical characteristics: Oblong, transparent amber softgel; 18×7.5 mm; density: 0.96 g/mL; residual moisture <1%

• Packaging options: Industrial bulk: 5 kg HDPE pails with nitrogen flush; or 25 kg fiber drums lined with food-grade polyethylene

• Shelf life: 24 months from manufacture when stored at 15–25°C, away from direct light (accelerated stability study ISO 14534 compliant)

3. Core Industrial Applications

• Primary industries: Nutraceutical manufacturing, sports nutrition, veterinary supplements, and functional beverage concentrates

• Operational use cases:

  • White-label private-label softgel runs for retail sleep/anxiety SKUs

  • Bulk ingredient for encapsulation into gummies, tablets, or chewables

  • Standardized additive for topical creams and transdermal patches

• Performance advantage over alternatives: Unlike crude oil or isolate, PlusCBD delivers the entourage effect with verified minor cannabinoid ratios, reducing required dosage per unit by 18–22% (in-house human bioavailability study). Also eliminates winterization step for formulators.

• Cost advantage: 30% lower total cost-in-use than isolate-plus-terpene reconstructions due to single-step full-spectrum sourcing.

4. Competitive Advantages

• Quality consistency: ISO 17025-certified third-party batch testing for potency, pesticides (66-panel), residual solvents, and microbiology. Certificate of Analysis (CoA) included with every pallet.

• Supply reliability: Vertically integrated from US-grown industrial hemp (Colorado/Kentucky) to encapsulation; 99.3% on-time in-full delivery rate over 18 months (audited).

• Logistics capability: Temperature-controlled warehousing in Rotterdam, Chicago, and Shanghai for regional just-in-time release.

• Price competitiveness: Tiered pricing achieving <$0.12 per 25 mg softgel at scale (20 MT volume).

• Sustainability & documentation: Carbon-neutral encapsulation line; full EU Novel Food compliance dossier and US FDA GRAS self-affirmation documentation provided under NDA.

5. Commercial & Supply Information

• Minimum order quantity (MOQ): 500 kg (approx. 1 pallet) for first commercial order; 200 kg for qualification samples

• BULK 20MT loading capacity: 20 metric tons net = 800 fiber drums (25 kg each) or 400 HDPE pails (50 kg each)

• MT per container:

  • 20-ft dry container: 14 MT max (palletized)

  • 40-ft high-cube container: 20 MT (floor-loaded, with desiccant packs)